Preterm Birth Clinical Trial
Official title:
Prenatal Breast Pumping Education of Mothers and Their Support Person
Verified date | May 2024 |
Source | University of Florida |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test whether antenatal education of the support person of mothers may decrease time to initiation of breast pumping, decrease time to lactogenesis stage II and increase breast milk production.
Status | Completed |
Enrollment | 90 |
Est. completion date | May 4, 2022 |
Est. primary completion date | May 4, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - English speaking - stated intent to breastfeed - anticipating the birth of a premature infant < 35 weeks gestation. Exclusion Criteria: - known illicit maternal drug use - history of breast reduction or augmentation - positive HIV status - infant not expected to live over 2 weeks following delivery. |
Country | Name | City | State |
---|---|---|---|
United States | UF Health at the University of Florida | Gainesville | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Florida |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Onset of Lactogenesis Stage II Through Volume Attainment | Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions | Up to 96 Hours | |
Secondary | Breast Milk Production on Day 1 | Volume of breast milk produced from 0-24 hours postpartum | 0-24 hours postpartum | |
Secondary | Time to Breast Pumping Initiation | Time to mothers beginning to pump breasts after delivery | first 24 hours after delivery | |
Secondary | Breast Milk Production Day 2 | Volume of breast milk produced on day 2 postpartum | Day 2 postpartum | |
Secondary | Milk Production Day 3 | Volume of milk produced on Day 3 postpartum | 3 days postpartum | |
Secondary | Breast Milk Production Day 4 | Volume of breast milk produced on Day 4 postpartum | Day 4 postpartum | |
Secondary | Breast Milk Production on Day 5 | Volume of breast milk produced on Day 5 postpartum | Day 5 postpartum | |
Secondary | Breast Milk Production Day 6 | Volume of breast milk produced on Day 6 postpartum | Day 6 postpartum | |
Secondary | Breast Milk Production Day 7 | Volume of milk produced on Day 7 postpartum | Day 7 postpartum | |
Secondary | Breast Milk Production Day 14 | Volume of breast milk produced on Day 14 postpartum | Day 14 postpartum | |
Secondary | Breast Milk Production Day 21 | Volume of breast milk produced on Day 21 postpartum | 21 days postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04811742 -
Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn
|
N/A |